Pulse Biosciences, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Pulse Biosciences, Inc. (PLSE) on November 18, 2021, with the earliest event reported on that same date. The filing addresses changes to the composition of the Company's Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
- Election of Director: The Board elected Shelley D. Spray effective November 24, 2021. Ms. Spray brings over 25 years of healthcare industry experience, including executive roles at Summit Therapeutics, Aesthera Corporation, Xlumena Inc., Intuitive Surgical, and Medtronic, Inc.
- Director Resignation: Laureen DeBuono resigned from the Board and all committees effective November 18, 2021, due to expanding previous work commitments. The resignation was not the result of any disagreement with the Company.
Compensation and Governance Details
Ms. Spray's compensation package includes:
- An annual retainer of $40,000, paid in quarterly installments (pro-rated until the next annual meeting).
- An initial stock option grant to purchase 32,500 shares, vesting one-third on the one-year anniversary and the remainder monthly over two years.
- Eligibility for annual stock option grants of 20,000 shares, vesting monthly over one year, beginning at the first annual meeting after her initial award.
- Reimbursement for reasonable out-of-pocket expenses.
Key Facts for Investor Verification
- Verify the impact of the Board composition change on the Company's strategic direction, particularly regarding commercialization and marketing expertise.
- Confirm the total number of outstanding shares and the dilution effect of the new director option grants (32,500 initial shares).
- Review the Company's most recent 10-K or 10-Q filings for current financial metrics, as this 8-K does not contain financial data.
- Monitor the timeline for the next annual meeting of stockholders to confirm Ms. Spray's term expiration and potential re-election.